- Record: found
- Abstract: not found
- Article: not found
Treatment of failed aortic bioprostheses: An evaluation of conventional redo surgery and transfemoral transcatheter aortic valve-in-valve implantation
Felix J. Woitek ,
Georg Stachel ,
Philipp Kiefer ,
Stephan Haussig ,
Sergey Leontyev ,
Florian Schlotter ,
Meinhard Mende ,
Jennifer Hommel ,
Lisa Crusius ,
Aileen Spindler ,
Friedrich W. Mohr ,
Gerhard Schuler ,
Holger Thiele ,
Michael A. Borger ,
Axel Linke ,
David Holzhey ,
Norman Mangner
October 2019
October 2019
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The use of bioprostheses for surgical aortic valve replacement increased substantially
within the last years. In case of prosthesis failure, re-SAVR is standard of care,
whereas valve-in-valve deployment of a transfemoral transcatheter aortic valve prosthesis
(VinV-TFAVI) has recently emerged as an alternative. We sought to evaluate early safety,
clinical efficacy, and all-cause 1-year-mortality of VinV-TFAVI and redo surgery for
failing aortic bioprostheses (re-SAVR).